Dr. Michael Snyder

They'll say, well, were you ill yesterday or something like that?

All that explains it.

Let's ignore it.

Come back in two years.

And that's just not enough.

And that might have been a clue for something big.

And we've seen that in our study.

We'll see somebody who shifted off their liver enzymes and they'll come to me and say, Mike, I'm still in the normal range even.

And this is why we're big on baselines.

That's a big theme in our work.

No way you're healthy baseline is like the MRIs.

And they'll be running in the low end of a normal range for their liver enzyme and suddenly it'll double but still be in a normal range.

And they'll call me up and say, hey, what's going on here?

I say, I don't know.

Why don't you go get another measurement?

Sure enough, then they shift it out of normal.

So I think the trajectories of these measurements is key.

I think knowing how you're progressing is a big deal, and that's how we think about

just like your car.

If you see something going off, you want to see it when you catch the first symptoms, not once your car is broken down on the side of the road, the engine's blown up or something.